impaired endothelium-dependent vasodilatation in uraemic patients, a defect that may predispose this Background. Patients with chronic renal failure (CRF ) have a substantially increased risk of cardiovascular group to accelerated atherosclerosis. death, the proposed mechanisms being arrhythmias Keywords: cardiovascular disease; forearm plethysmog-( left ventricular hypertrophy) and accelerated atheroraphy; hypertension; nitric oxide; uraemia; vascular sclerosis. The vascular endothelium protects against endothelium the development of atherosclerosis principally by releasing vasoactive substances such as nitric oxide (NO) and endothelium-derived hyperpolarizing factor.
Impaired endothelium-dependent vasodilatation in uraemia 1195 taking a beta-blocker, and one patient was on doxazosin.
-arginine analogues such as NG-monomethyl -argin-
No patients or controls were taking aspirin.
ine and asymmetric dimethylarginine (ADMA), endoAll subjects were studied in the morning after an overnight genous substances known to accumulate in CRF [5] .
fast, and were asked to omit anti-hypertensive medication In addition to NO, the vascular endothelium pro-for at least 48 h before the study. Subjects were asked to duces other vasodilating substances including prostacy-avoid caffeine and alcohol, and to refrain from smoking, for clin and endothelium-derived hyperpolarizing factor, at least 12 h prior to the study. which also contribute to resting vascular tone. Stimulation of the vascular endothelium with an agonist such as acetylcholine (or carbachol as in this study) Plethysmography will release endothelium-derived hyperpolarizing factor as well as NO.
Forearm strain-gauge plethysmography works on the principle that during short-term venous occlusion of the forearm, This present study was designed to examine endothe rate of distension of the forearm is proportional to the thelium-dependent vasodilatation in adult uraemic rate of arterial inflow into the forearm. Forearm blood flow patients compared to controls using bilateral forearm (FBF ) can be measured at rest and after infusion of drugs.
strain-gauge plethysmography.
All forearm studies were performed in a sealed, soundproofed, vascular research laboratory maintained at 24-26°C. Subjects lay supine with arms supported above
Subjects and methods
heart level on foam blocks. Paediatric cuffs (Hokanson TMC-7, PMS Instruments, Maidenhead, UK ) were placed around the wrists, and inflated to at least 40 mmHg above Subjects systolic blood pressure for 3 min during each recording, to exclude the hand circulation from the system. Collecting Patients with advanced renal failure (median creatinine 786 mmol/l ) were recruited from the pre-dialysis (n=10) and cuffs (Hokanson SC10) were placed around the upper arms and inflated (40 mmHg) and deflated in 15-s cycles. Rapid continuous ambulatory peritoneal dialysis (CAPD, n=6) clinics at the Western Infirmary, Glasgow. Controls without cuff inflation was achieved using a Hokanson AG101 air source linked to two Hokanson E20 rapid cuff inflators. renal disease were obtained from hospital staff and by advertisement. All subjects gave written informed consent, Blood pressure was measured at the end of each blood flow recording, using a semiautomatic oscillometric sphygmomaand the protocol was approved by the local ethics committee.
The patient and control groups were comparable for age, nometer (Critikon Dinamap Plus, FL, USA) placed around the dominant arm, over the collecting cuff. sex, and body mass index, and had similar smoking habits and serum cholesterols. Background characteristics for
The maximal circumference of the forearm was measured and a mercury-in-silastic strain gauge (Hokanson forearm patients and controls are detailed in Table 1 .
Patients were excluded if they were currently anti-set) chosen 2 cm shorter than the circumference. Strain gauges were calibrated electrically while in position using a coagulated, had a history of diabetes mellitus or vasculitis, or were taking anti-anginal medications or statins. Patients built-in calibration method.
Under local anaesthesia (1 ml 1% lignocaine), a sterile were also excluded if they had severe hypertension such that anti-hypertensive drugs could not be withheld prior to the 27-gauge dental needle ( Terumo, Japan) was inserted into the brachial artery of the non-dominant forearm. The needle study, or if they had previously been treated by haemodialysis and had functioning AV fistulae. For those patients on was connected to an IVAC infusion pump using a modified 16-gauge epidural giving set (Portex, Hythe, UK ), and drugs CAPD the median (range) time on dialysis was 11.5 (7-32) months. Nine of the 16 patients were taking anti-hypertensive or 0.9% saline were infused throughout the study at 1 ml/min.
Baseline measurements of FBF were obtained at 10-min drugs: seven were taking a calcium-channel blocker, six were intervals for 30 min to allow acclimatization to inflation and Mann-Whitney test. Statistical significance was defined at the 5% level. deflation of the cuffs. The final baseline reading was used as the baseline FBF.
Results

Infusion protocol
The two groups had a similar age and sex distribution, ( Table 1) . Total serum cholesterol was 10 .0 mg/min) were commenced. There was a 30-min washout similar in patients and controls, although the fasting period with 0.9% saline between drug infusions and the order serum triglyceride level was significantly greater in of drugs infused was randomized between subjects in blocks patients. Both systolic and diastolic blood pressures of 10. The protocol is illustrated in Figure 1 . All drug were higher in uraemic patients, and the uraemic solutions were prepared in 0.9% saline in the sterile pharmacy patients had lower haemoglobin concentrations.
productions unit in the hospital. Each drug was infused for 7 min with FBF measurements taken from min 3-6, and blood pressure recorded in the seventh minute. During each Effect of infusion of carbachol and SNP in all subjects drug infusion, several FBF measurements were made; the Overall there was no difference in response of the two mean of the final five readings was taken as the FBF achieved groups to infusion of carbachol or SNP. The area for each dose of drug.
under the curve for infusion of carbachol in uraemic FBF is expressed as millilitres blood flow/min/ 100 ml forearm [6 ] . Bilateral FBF measurements were made, patients was 487.9 (150.8-1180.3) compared to 598.4 and results expressed as a ratio of infused:non-infused arm, (191.5-1576.6) for controls, P=0.463. The AUC for since this method is more reproducible than unilateral ple-infusion of SNP in uraemic patients was 1867.4 thysmography [7] , and corrects for background variation in (216.6-3521.4) compared to 1734.6 (857.8-4717.1) for FBF. The response to a particular drug infusion rate was controls, P=0.986. The higher AUC values for SNP calculated as the percentage change in FBF ratio from compared to carbachol simply reflect the higher doses baseline.
of drug used.
When performing the studies it became clear that Statistical comparison there was a drug order effect which was introducing error. Despite a 30-min wash-out period, infusion of Results are expressed as median (range) unless otherwise SNP as the first drug appeared to have an unusually specified. For each dose response curve, area under the curve prolonged effect, such that the second baseline was (AUC ) was calculated using the trapezoid rule [8] . This rarely equivalent to the first. The infusion of SNP as simply involves measuring the area under each section of a the first drug therefore blunted the subsequent response dose-response curve, and calculating an overall area under to carbachol. This is illustrated in Figure 2 , where the curve. The benefit of this method is that a single patients and controls combined as a group are split 'summary' measure is given for each dose-response curve, allowing easy statistical comparison between groups by into those who received carbachol as the first or second drug. It can be clearly seen that the response to not differ significantly between the two groups: 1328.1 (216.6-3311.4) for uraemic patients compared to carbachol is markedly attenuated if it is infused after SNP.
1475.0 (857.8-4717.1) for controls; P=0.545).
Blood pressure Effect of infusion of carbachol and SNP in subgroup of subjects in whom SNP was infused last
As the doses of drugs were chosen to act only on the forearm, blood pressure did not change significantly When those patients (n=10) and controls (n=10) who throughout the studies ( Tables 3 and 4 ) except for a received carbachol first followed by SNP are examined small decrease in diastolic blood pressure after infusion as a subgroup, results are clearly different. The backof SNP in controls. ground characteristics of this subgroup are detailed in Table 2 ; patients and controls are again matched for age, sex, smoking habits, and serum cholesterol. The Discussion response to infusion of carbachol is depicted in Figure 3 and to SNP in Figure 4 . For infusion of carbachol, the AUC was significantly reduced in The vascular endothelium provides a strategic barrier between the circulating blood and the tissues. uraemic patients: 529.0 (150.9-834.7) for uraemic patients compared to 703.9 (583.5-1576.6) for con-Endothelial dysfunction is thought to be a key initial event in the development of atherosclerosis, a principal trols; P=0.028. For infusion of SNP, the AUC did renal disease. However, the infusion of SNP first appeared to blunt the subsequent response to carbamechanism being through a loss or reduction in effect of the anti-atherogenic molecule NO. This study was chol, perhaps owing to a more prolonged effect of SNP. This feature has not previously been described designed to examine endothelium-dependent vasodilatation in adult patients with advanced uraemia.
in plethysmography, and is important for planning future studies. We therefore excluded those patients Results from all subjects demonstrated similar vasodilatation to both carbachol (endothelium-dependent and controls who had received SNP first from subsequent analysis. Ten patients and controls were comvasodilator) and SNP (endothelium-independent vasodilator) in both uraemic patients and controls without pared, in whom carbachol was infused first followed by SNP, and these groups were again comparable in aemia impairs endothelium-dependent vasodilatation [18] . Hyperhomocysteinaemia is 100 times more age, sex, cholesterol, and smoking habits ( Table 2 ). In this substudy the pattern of normal vasodilatation to common in dialysis patients than the general population, and may therefore be one link explaining endo-SNP but impaired vasodilatation to carbachol indicates a reduced ability of the vascular endothelium in thelial dysfunction and accelerated atherosclerosis in uraemia. uraemic patients to produce and release vasodilator substances upon stimulation.
Our results are in keeping with those reported from non-invasive studies in uraemic children [19] and in This pattern of endothelial dysfunction has previously been described in hypercholesterolaemia [9] , adult haemodialysis patients [20] . We believe that it is likely that endothelial dysfunction develops at the smoking [10] , and diabetes [11] and is thought to predispose to the development of atherosclerosis. In earliest stages of renal disease when glomerular filtration rate begins to fall and blood pressure rises. This our study, diabetics were excluded and patients had similar smoking habits and serum cholesterol levels to raises the issue of what can be done to treat or reverse endothelial dysfunction, and at what stage therapy controls. However, blood pressure was significantly higher in the uraemic patients, as would be expected, should be commenced. Several 'drugs' are known to improve endothelial function, including angiotensinalthough the median blood pressure in this group was only 140/81 mmHg. It is widely believed that hyper-converting enzyme (ACE) inhibitors [21] , statins [9] , -arginine [20] , and vitamin C [22] . Surprisingly, a tension is associated with endothelial dysfunction, although it is not known whether the endothelial study in CAPD patients with folic acid supplementation (which lowers homocysteine significantly) dysfunction is a primary defect (unlikely) or whether it occurs as a response to the elevated blood pressure. failed to improve endothelial function [23] . Lifestyle modification, for example, cessation of smoking, may While a number of studies have demonstrated endothelial dysfunction in essential hypertension [12, 13] , also reverse endothelial dysfunction [10] .
Forearm plethysmography is a powerful technique one plethysmography study by Cockcroft et al. [14] failed to demonstrate this, and the issue remains con-with which to study the effects of vasoactive drugs in vivo. It has drawbacks, however, in that intra-subject troversial. We were unable in this present study to match patients and controls for blood pressure, but variability has been estimated to be around 19% [7] .
We did not measure intra-subject variation in this further larger studies are warranted to compare endothelial function in uraemic and essential hypertensive study, as it would have necessitated two arterial cannulations. Our results are also limited by small numpatients.
Our patient and control groups also differed with bers, although plethysmography studies are often small, as recruitment of subjects can be difficult because respect to triglyceride and haemoglobin levels. Hypertriglyceridaemia, while being an independent of the arterial puncture and the requirement for subjects to lie still for 2-3 h. cardiovascular risk factor, is not thought to affect endothelial function adversely [15] . In contrast, as NO In summary, this study has demonstrated a marked drug order effect with the technique of forearm plethysbinds avidly to the haem moiety of haemoglobin, changes in haemoglobin concentration could theoretic-mography such that randomization of the drug order when using SNP is inadvisable, and SNP should be ally alter the response to endothelium-dependent vasodilators. However, in our study the uraemic patients infused at the end of a protocol. When this order effect was taken into account, we demonstrated impaired had lower haemoglobin concentrations and would, if anything, be expected to have an exaggerated response endothelium-dependent vasodilatation in uraemic patients compared to controls, the exact mechanisms to carbachol, as NO would theoretically have a longer half-life. This was not seen, and the effects of anaemia involved being unclear. It is likely that endothelial dysfunction develops at an early stage in renal disease, in this situation are therefore not clear.
The pattern of endothelial dysfunction demonstrated and that this predisposes to the development of atheroma. Several treatments including ACE inhibitors, by this technique in uraemic patients may reflect a direct inhibitory effect of circulating factors such as statins, anti-oxidants, folate, and -arginine may modulate endothelial function, and should be assessed ADMA on eNOS, although there is debate about whether ADMA levels reach physiological significance. further in this high-risk population. It is also possible that the impaired endotheliumdependent vasodilatation is secondary to the effects of Acknowledgements. Dr Morris is funded through a British Heart higher blood pressures in the uraemic patients as Foundation Junior Fellowship. opposed to control subjects, or to the damaging effects of increased oxidative stress.
Another potential atherogenic 'uraemic factor' may References be homocysteine, an amino acid that accumulates in
